150 related articles for article (PubMed ID: 30528355)
21. [Hemorrhagic Onset of Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis:A Case Report and Review of Literature].
Adachi M; Nakamura M; Shinozaki N; Miyazaki T
No Shinkei Geka; 2017 May; 45(5):397-404. PubMed ID: 28490681
[TBL] [Abstract][Full Text] [Related]
22. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
23. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
Skalicky AM; Rentz AM; Liu Z; Wheless JW; Pelletier CL; Dunn DW; Frost MD; Nakagawa J; Magestro M; Prestifilippo J; Pashos C
J Child Neurol; 2015 Apr; 30(5):563-9. PubMed ID: 24667738
[TBL] [Abstract][Full Text] [Related]
24. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
25. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Fogarasi A; De Waele L; Bartalini G; Jozwiak S; Laforgia N; Verhelst H; Petrak B; Pedespan JM; Witt O; Castellana R; Crippa S; Gislimberti G; Gyorsok Z
BMC Neurol; 2016 Aug; 16():126. PubMed ID: 27502586
[TBL] [Abstract][Full Text] [Related]
26. Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex.
Bai D; Zhao J; Li L; Gao J; Wang X
Sci China Life Sci; 2017 Jul; 60(7):763-771. PubMed ID: 28623545
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma multiforme with tuberous sclerosis. Report of a case.
Padmalatha C; Harruff RC; Ganick D; Hafez GB
Arch Pathol Lab Med; 1980 Dec; 104(12):649-50. PubMed ID: 6254467
[TBL] [Abstract][Full Text] [Related]
28. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.
Prato G; Mancardi MM; Baglietto MG; Janis S; Vercellino N; Rossi A; Consales A; Raso A; Garrè ML
J Child Neurol; 2014 Sep; 29(9):NP54-7. PubMed ID: 24056156
[TBL] [Abstract][Full Text] [Related]
29. Tuberous sclerosis and epilepsy: role of astrocytes.
Wong M; Crino PB
Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
[TBL] [Abstract][Full Text] [Related]
30. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
31. An unusual tuberous sclerosis case presenting with fibrillary astrocytoma.
Eren S; Polat P; Erman Z
Pediatr Neurosurg; 2002 Sep; 37(3):118-21. PubMed ID: 12187056
[TBL] [Abstract][Full Text] [Related]
32. Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.
Kwiatkowski DJ; Palmer MR; Jozwiak S; Bissler J; Franz D; Segal S; Chen D; Sampson JR
Eur J Hum Genet; 2015 Dec; 23(12):1665-72. PubMed ID: 25782670
[TBL] [Abstract][Full Text] [Related]
33. Subependymal giant cell astrocytoma with tuberous sclerosis--case report.
Lee WY; Wang YC; Cho DY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Aug; 10(8):474-8. PubMed ID: 7799469
[TBL] [Abstract][Full Text] [Related]
34. Enhancing cyst-like lesions of the white matter in tuberous sclerosis complex: a novel neuroradiological finding.
D'Amico A; Perillo T; Russo C; Ugga L; Melis D; Santoro C; Piluso G; Cinalli G
Neuroradiology; 2021 Jun; 63(6):971-974. PubMed ID: 33481070
[TBL] [Abstract][Full Text] [Related]
35. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD).
Kingswood C; Bolton P; Crawford P; Harland C; Johnson SR; Sampson JR; Shepherd C; Spink J; Demuth D; Lucchese L; Nasuti P; Gray E; Pinnegar A; Magestro M
Eur J Paediatr Neurol; 2016 Mar; 20(2):296-308. PubMed ID: 26706603
[TBL] [Abstract][Full Text] [Related]
36. Novel TSC1 and TSC2 gene mutations in Chinese patients with tuberous sclerosis complex.
Yu T; He Y; Li N; Zhou Y; Wang Z; Fu Q; Wang J; Wang J
Clin Neurol Neurosurg; 2017 Mar; 154():104-108. PubMed ID: 28178598
[TBL] [Abstract][Full Text] [Related]
37. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex.
Harter DH; Bassani L; Rodgers SD; Roth J; Devinsky O; Carlson C; Wisoff JH; Weiner HL
J Neurosurg Pediatr; 2014 Jan; 13(1):21-8. PubMed ID: 24180681
[TBL] [Abstract][Full Text] [Related]
38. [Tuberous sclerosis without mental impairment, diagnosed in adulthood].
Timotin L; Sarrot-Reynauld F; Lantuejoul S; Pasquier B; Massot C; Ashraf A; Borgel F
Rev Med Interne; 2005 Jun; 26(6):511-3. PubMed ID: 15936480
[TBL] [Abstract][Full Text] [Related]
39. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
40. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.
Bjornsson J; Short MP; Kwiatkowski DJ; Henske EP
Am J Pathol; 1996 Oct; 149(4):1201-8. PubMed ID: 8863669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
